alexa
Indianmoney.com Missed Call Number
 
Home News Alembic Pharma up 3%, gets tentative USFDA nod for ANDA

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Demat and Trading Accounts Click Here
 
Alembic Pharma up 3%, gets tentative USFDA nod for ANDA

Alembic Pharma up 3%, gets tentative USFDA nod for ANDA

Wednesday, April 19, 2017, 11:27 AM

Shares of Alembic Pharmaceuticals advanced 3 percent intraday Wednesday as it has received tentative approval from USFDA for Vilazodone Hydrochloride tablets. “The company has received tentative approval from United States Food and Drug Administration for its ANDA for Vilazodone Hydrochloride tablets, 10 mg, 20 mg and 40 mg," as per company release. Vilazodone Hydrochloride tablets are indicated for the treatment of major depressive disorder.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!